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INTRODUCTION:  Chyle  leak  after  oesophagectomy  is highly  morbid  and  may  carry  signiﬁcant  mortality  if
treatment  is delayed.  Identiﬁcation  of  the site  of leakage  and  surgery  may  be  plagued  by  failure.
PRESENTATION  OF  CASE:  We  describe  a case  of  chyle  leak after  oesophagectomy.  Lymphangiography
revealed  the  site  of chyle  leak  to  be  an  aberrant  duct  that  would  have  been  difﬁcult  to  identify  surgically.
Radiological  coiling  and  embolization  successfully  treated  the  leak.
DISCUSSION:  The  gold  standard  for treatment  of  chyle  leak  or  chylothorax  after  oesophagectomy  was  a
re-operation,  either  open  or throracoscopic,  to ligate  the  thoracic  duct.  The  interventional  radiological
technique  employed  in our  case  was  not  only  efﬁcacious  in stopping  the  leak,  but had the  added  advantage
of  identifying  the site  and  highlighting  the  anatomy  hence  avoiding  a morbid  reoperation.  The  literature
is  reviewed.
CONCLUSION:  The  report  and  review  conﬁrm  that  lymphangiography  followed  by  coiling  and  emboliza-
tion  for chylothorax  post  oesophagectomy  is  safe  and  effective  in  a majority  of  cases.
©  2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Thoracic duct anatomy must be understood in the context of its
mbryology. The ﬁrst lymph sacs to develop in the human body
re the paired jugular lymph sacs at the junction of the internal
ugular and subclavian veins. The jugular lymph sacs communi-
ate inferiorly with the cisterna chyli. Channels that join the jugular
ymph sacs to the cisterna chyli become the thoracic duct (left lym-
hatic duct) and the right lymphatic duct. Disturbances in processes
hat govern the formation of these lymphatic channels can result
n anatomical variations of the thoracic duct [1–3].
The thoracic duct is a tubular structure that is 2–3 mm in diame-
er and varies in length from 38 to 45 cm.  It begins in the abdomen at
he level of the second lumbar vertebra. It enters the thorax through
he aortic opening of the diaphragm between the aorta and the
zygous vein. The thoracic duct then passes cephalad on the right
ide of the aorta and crosses to the left side at the level of the ﬁfth
ervical vertebra where it joins the venous system. The previously
escribed course of the thoracic duct has an incidence of 60–65%.
he thoracic duct may  also be partially duplicated in 15–20% of the
ime or fully duplicated in 15%. These anatomical variations pro-
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E-mail addresses: moatiemd@yahoo.com (M.  Atie), dunng@email.cs.nsw.gov.au
G. Dunn), sydney.heartburn@gmail.com (G.L. Falk).
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210-2612/© 2016 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing G
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
vide a reason why  the thoracic duct gets damaged during surgery
despite the surgeon’s vigilance [3–5].
The complication rate of oesophageal surgery is relatively high,
in the region of 30–40%. The thoracic duct can often be damaged
during mobilisation of advanced oesophageal cancers, whether
via a right thoracotomy or through the trans-hiatal route. A com-
prehensive review reports chylothorax occurring in up to 10%
of patients after blunt trans-hiatal oesophagectomy [6]. An inci-
dence of 2–3%, during open trans-thoracic resection, is commonly
reported [7].
In the event of thoracic duct injury, chylothorax usually presents
in the ﬁrst 7 days after surgery, when the patient has commenced
oral intake, or jejunostomy feeds. A massive increase in chest
drainage occurs that if left untreated, results in malnutrition and
signiﬁcant immune suppression, with a markedly reduced CD4
count from the subsequent white cell loss [8].
Leaks of less than 500 mL/day may  resolve with enteral feed-
ing using medium-chain triglyceride. Octreotide/somatostatin and
etilefrine therapy may  also be highly efﬁcacious in the conservative
management of low volume chylothorax. High volume leaks, how-
ever, warrant immediate re-exploration as the damaged thoracic
duct is usually easily identiﬁed, following a bolus of “cream” at the
time of re-exploration [7]. Open or thoracoscopic exploration had
been established as the gold standard of treatment.
We describe a case of chyle leak post radical 2- stage
oesophagectomy (Ivor-Lewis) with two-ﬁeld lymph node dissec-
tion. The gold standard of treatment that we grew accustomed
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. (a) and (b) coronal and transverse views: “white out” resulting from a large
left  pleural effusion.CASE  REPORT
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o was not employed in the management of our case but rather
ymphangiography was used to identify the anatomy and the site
f the leak. The leak was then successfully treated by means of
adiological coiling and embolization.
. Case report
A 69-year-old male presented with dysphagia to solids and vom-
ting. Weight loss was denied, and appetite was good. Past medical
istory was signiﬁcant for hypercholestrolaemia, diverticular dis-
ase, renal calculi, parathyroidectomy for hyperparathyroidism
nd benign prostatic hypertrophy.
Endoscopy revealed a Seiwert I type junctional/distal
esophageal cancer. Biopsies conﬁrmed adenocarcinoma. Radiol-
gy including CT, EUS and PET staged this tumour at T3N0M0. The
ancer multidisciplinary meeting consensus was that the criteria
or “Magic Protocol” were met.
Treatment with 3 cycles of ECF was followed by radical subtotal
esophagectomy (Ivor-Lewis) with two-ﬁeld lymph node dissec-
ion. A feeding jejunostomy was fashioned during the abdominal
tage as is routine in our practice. The thoracic duct was  excised
uring the chest stage of the operation. An apical, basal and
ediastinal chest tubes were inserted for drainage. Thoracic
nd abdominal “pain buster” catheters were positioned intra-
peratively for analgesia.
The patient was managed according to our enhanced recovery
rogram. He was mobilized out of bed on the evening of surgery.
ivonex (Nestle Health Science, U.S.A), low fat jejunostomy feeding,
as commenced at a rate of 25 mls/hour on day 1 post surgery and
as increased by 25 mls  every 24 h to a maximum of 75 mls/hour
n day 3 post surgery. The output in the chest drains combined
veraged less than 200 mls/day on day 3. There was minimal out-
ut in the apical drain and therefore it was removed. The basal and
ediastinal drains were left in place until a time when radiologi-
al assessment of the anastomosis was feasible. Contrast swallow
n day 5 conﬁrmed anastomotic integrity and demonstrated good
astric emptying. Apical and basal chest drains were removed by
ay ﬁve, as there was minimal drainage. Chest X-rays showed clear
ung ﬁelds bilaterally.
Acute respiratory failure developed on day 8 post operatively.
he patient was re-admitted to the intensive care unit. Inves-
igations including CT pulmonary angiogram demonstrated the
resence of a large effusion on the left side, almost obliterating
he entire pleural space (Fig. 1a and b). The right pleural space
as unremarkable. All other pathology was excluded. Ultrasound
uided drainage of the left pleural effusion revealed that it was chy-
ous in nature. A pigtail drain was inserted in the left chest cavity
nd a trial of conservative therapy was commenced. Jejunostomy
eeds were ceased. Total paraenteral nutrition was  commenced.
antoprazole 40 mgs  IV twice daily and Octreotide 200 units SC
hree times daily were given to slow down gut function.
It is our experience that when a major chyle leak ensues as a
esult of thoracic duct damage, the volume produced is usually
igh from the onset. What was intriguing in this case report was
he delayed onset of the chyle leak despite having commenced
ejunostomy feeding from day 1 post operatively.
Unfortunately, a 5-day trial of conservative therapy was fraught
ith failure. At almost 2 weeks since surgery, it was  felt that the
ondition of the tissues in the thorax at that point of time would not
avour surgical intervention. A radiological approach was  therefore
ought.Percutaneous thoracic duct embolization was arranged. Tech-
ique: a 25-gauge needle was introduced into the largest right
uperﬁcial inguinal lymph node under ultrasound guidance. Lip-
odol was injected to opacify the lymphatic system up to thecysterna chyli, which was at the level of T12/L1 disc (Fig. 2a).
The cysterna chyli was then punctured with a 22-gauge needle
and a V18 guidewire (Boston Scientiﬁc, U.S.A) was introduced.
The latter was  exchanged for a Renegade microcatheter (Boston
Scientiﬁc,U.S.A), which was used to perform a lymphangiogram
with the water-soluble contrast medium ioversol 370 ﬂushed with
5% dextrose (anticipating the use of cyanoacrylate which sets in
the presence of ionic solutions). The lymphangiograms showed
the presence of an aberrant thoracic duct running to the left of
the thoracic vertebral column. There was extravasation of con-
trast medium at the level of T9 (Fig. 2b). A small channel draining
towards the right main duct was also seen. The main duct did not
opacify consistent with surgical obliterated. Three Tornado coils
50 mm  in length and 0.018 in. in diameter (Cook Medical, U.S.A)
were deployed in the aberrant duct near the region of extravasation.
This was followed by injection of 1 ml  of cyanoacrylate (Histoacryl
by Braun, Germany) mixed with Lipiodol ultra ﬂuid (Guerbet,
France). A repeat lymphangiogram conﬁrmed the absence of fur-
ther extravasation (Fig. 2c)
Flow from the left pleural drain slowed and drainage had almost
ceased by day 2 after the procedure. No pleural ﬂuid was  visible
on a radiograph of the chest nine days after the lymphangiogram
and embolization. The patient’s diet was upgraded and he was dis-
charged day 5 post procedure (13 days post-operation).
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rig. 2. (a) Lymphangiogram: Lipoiodol injected into superﬁcial inguinal node ﬁlls 
rrows) extravasation at T9 (white arrow). A single black arrow points towards a s
nd  embolization (black arrow). The side branch has also been occluded.
. Discussion
Chylothorax after oesophagectomy should be suspected when
here is an unexplained high-volume chest tube output which could
ppear milky after enteral tube feeding is commenced. The exact
iagnosis of chylothorax is based on the presence of chylomicrons
n the pleural ﬂuid. Chylomicrons are molecular complexes of pro-
eins and lipids that are synthesised in the jejunum and transported
ia the thoracic duct to the circulation. They are only found in the
irculation post-prandially with a peak 3 h after eating [9]. Cyto-
ogical analysis of ﬂuid stained with Sudan III will demonstrate
hylomicrons, which although sensitive, is not speciﬁc and there-
ore should be combined with complementary ﬂuid analysis. In
entres with available facilities, lipoprotein analysis demonstrating
hylomicrons is the gold standard. Where this facility is not avail-
ble, institutions rely on the measurement of ﬂuid cholesterol and
riglyceride levels. A pleural ﬂuid triglyceride levels >1.24 mmol/l
110 mg/dl) with a cholesterol <5.18 mmol/l (200 mg/dl) is diagnos-
ic of chylothorax [5]
Alexiou et al. [10] carried out a retrospective analysis of 523
atients with cancer of the oesophagus or the gastro-oesophageal
unction who underwent oesophageal resection between January
987 and November 1997. Chylothorax occurred in 21 patients
4.0%). Radicality of dissection was the only apparent predisposing
actor.
The management of early post-operative chylothorax requires
igorous scrutiny. The aetiology of the chylothorax, the ﬂow rate
nd patient condition dictate the preferred management. Interven-
ions are only required if unresponsive to medical management.
Surgical therapy is recommended in cases where despite con-
ervative management, the patient drains more than 1.5/day in an
dult or >100 ml/kg body weight per day in a child [11], leaks chyle
t a rate of >1 l/day × 5 days [8] or has persistent chyle ﬂow for more
han 2 weeks [12]. Surgery is also recommended if there has been a
apid decline in nutritional or immunological status despite conser-na chyli (white arrow). (b) Lymphangiogram: Aberrant left thoracic duct (2 black
nch of the thoracic duct. (c) Lymphangiogram: Occlusion of leak following coiling
vative management [13–15]. Chylothorax following oesophageal
surgery managed with re-exploration is associated with a mortal-
ity of 10% compared to a mortality of 50% if managed conservatively
[16,17].
Patients with iatrogenic chylothorax after oesophagectomy who
are good surgical candidates and in whom the site of the leak
is identiﬁed, do well following surgical re-exploration. When re-
operation is not delayed and simple duct closure of any type is
performed, patients have little added morbidity and the reported
success rates are around 90% [18]. Ligation of the thoracic duct via a
thoracotomy has been considered to be the gold standard approach.
Video-assisted thoracic surgery and ligation of the duct has also
proven to be a safe and effective approach [19].
Ligation of the thoracic duct is successful in 90% of patients when
performed just above the right hemi-diaphragm [20]. Ligating at
that site has the advantage of halting ﬂow from any unidentiﬁed
accessory ducts [21,22]. Collateral circulation re-directs the chyle
around the ligation point ensuring that the chyle still completes its
journey to the circulation. If the leak is in the region of the neck
or upper thorax, the thoracic duct is ligated in the area known as
Poirier’s triangle between the arch of the aorta, internal carotid and
vertebral column [23].
In thoracoscopic ligation, up to 3 ports are inserted strategi-
cally between different ribs and the thoracic duct is sought. A short
segment of the duct is excised before clipping the remaining ends
[13].
If the leak is not identiﬁable on either thoracoscopy or thora-
cotomy, then mass ligation of all the tissue between aorta, spine,
oesophagus and pericardium is performed [13]. Extensive dissec-
tion to ﬁnd the duct is discouraged reducing the risk of further
trauma and leak. Pleurectomy or pleurodesis with talc or glue have
been described as alternative options [24]. In cases of loculated
or complicated chylothorax, pleural decortication with pleurodesis
may  be performed [13]. In patients that are unﬁt for major surgery,
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 pleuroperitoneal shunt may  be useful. It minimises the nutritional
r immunological deﬁcits seen in chylothorax [20].
The accumulation of experience in treating chylous effusions has
igniﬁcantly broadened the adoption of thoracic duct embolization
o treat chylothorax. A cannulation and embolisation technique
sed by Cope et al. [25] to treat chylothorax was curative in patients
ith demonstratable duct leakage. However, reproducibility and
uccess rates have varied in different centres. More recently Boffa
t al. [26] have used the technique of thoracic duct embolisation
r disruption with very good effect in patients with chyle leak post
horacic surgery and Litherland et al. [27] described a case report
here CT guided disruption of the lymphatics had good effect in
he management of high output chylothorax.
Matsumoto et al., performed lymphangiography on 9 patients
hat were unlikely to respond to conservative measures. They found
hat lymphangiography not only identiﬁed the site of the leak but
lso led to the leak resolving in all cases. They recommend early
ymphangiography in cases unlikely to be cured by conservative
ethods only [28].
The feasibility and effectiveness of percutaneous thoracic duct
mbolization or interruption have been reported in four papers.
Marcon et al. [29] reviewed the existing literature on percuta-
eous management of chyle leaks. The authors evaluated ﬁve case
eries and three case reports inclusive of 90 patients in whom per-
utaneous treatment for chylothorax was attempted between 1998
nd 2004. Percutaneous treatment resulting in successful resolu-
ion of the chylothorax was achieved in 69% of the patients. The
uthors concluded that such percutaneous management of chyle
eaks is feasible, with low morbidity and mortality rates and a high
ate of effectiveness.
A retrospective review of 34 patients was similarly conducted by
adolski et al. [30] to assess the technical and clinical success of tho-
acic duct embolization for iatrogenic chylous effusions. Thoracic
uct embolization was technically successful in 24 of 34 patients
70.6%).
A retrospective review of 109 patients was conducted by Itkin
t al. [31] to assess the efﬁcacy of thoracic duct embolization or
nterruption for the treatment of high-output chyle leak caused by
njury to the thoracic duct. The authors concluded that catheter
mbolization or needle interruption of the thoracic duct is safe,
easible, and successful in eliminating a high-output chyle leak in
he majority (71%) of patients. Further more, the authors stated that
his minimally invasive procedure, although technically challeng-
ng, should be the initial approach for the treatment of a traumatic
hylothorax.
Pamarthi et al. [32] retrospectively report the indications, tech-
ical approach, and clinical outcomes of thoracic duct embolization
nd thoracic duct disruption in 105 patients with symptomatic chy-
ous effusions. The technical success rate was 79% in this series. The
uthors concluded that thoracic duct embolization and thoracic
uct disruption are safe and effective minimally invasive treat-
ents for traumatic thoracic duct injuries.
. Conclusion
TDE in this case was technically satisfactory. Chyle leak may
ccur from aberrant sites as in this case and lymphangiograohy
s helpful. High volume chyle leak requires prompt management
efore immune compromise occurs. TDE is successful in a majority
f cases (61–71%) and so should be utilised in reserving surgery for
ailed percutaneous management.onﬂict of interest
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